Literature DB >> 15529461

The acute effect of ACEI and ARB's upon endothelin in heart failure patients.

D Zdrenghea1, Dana Pop, G Bodizs, Mirela Cebanu, Ramona Rusu, C S Grosz.   

Abstract

PURPOSE OF THE STUDY: to compare the acute effect of ACEI and ARB's upon the plasmatic endothelin level in heart failure patients.
METHODS: There were studied 30 patients with congestive heart failure, III-IV functional NYHA class, that were not under ACEI or ARB's treatment. In all the patients the endothelinl-21 plasmatic level was determined. After this, 20 patients, representing group I, received a single dose of 1 mg trandolapril, and 10 patients, representing group II, received a single dose of 40 mg telmisartan. After 24 hours, the plasmatic endothelin 1-21 level was determined again.
RESULTS: The mean endothelial plasmatic level was similar in both groups (group I: 0.358+/-0.04 fmol/ml; group II: 0.345+/-0.038). After 24 hours, the endothelin level decreased to 0.295+/-0.03 fmol/ml for group I (p<0.05) and to 0.287+/-0.029 fmol/ml for group II (p<0.05), suggesting that both ACEI and ARB's are equally efficient in decreasing endothelin. The initial endothelinl-21 level was inversely correlated with LVEF (r = -0.989), and the degree of the decrease of endothelinl-21 after both ACEI and ARB's is directly correlated with the initial endothelinl-21 level (r =0.64).
CONCLUSION: The acute administration of ACEI and ARB's in heart failure patients decreases the endothelin level, both categories of drugs having the same effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15529461

Source DB:  PubMed          Journal:  Rom J Intern Med        ISSN: 1220-4749


  1 in total

1.  Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients--a comment.

Authors:  W Zehngawa
Journal:  Eur J Clin Pharmacol       Date:  2005-05-13       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.